CRA PLENIT REVIROST CUELL 50G AVIA OLUMIANT® 4 mg | Baricitinib

Description

OLUMIANT® 4 mg | Baricitinib | Tabletas

Presentación en empaque con 1 venda elástica

posteriormente cada 10–14 semanas

Uso en combinación con factores estimulantes de colonias (G-CSF) para movilización de células madre

FABRICANTE: ALPHARMA GENERICO

CRA PLENIT REVIROST CUELL 50G AVIA OLUMIANT® 4 mg | Baricitinib50 G Botella

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy